STUDY OF COMPARISON BETWEEN DACRYOCYSTORHINOSTOMY SURGERY WITH PAWAR’S IMPLANT AND CONVENTIONAL DACRYOCYSTORHINOSTOMY SURGERY
Keywords:
Dacryocystitis, DCR, Pawar’s Implant, lacrimal sacAbstract
Introduction: Dacryocystorhinostomy (DCR) is the treatment of choice for chronic Dacryocystitis which is associated with many complications. A newer surgical technique, Pawar’s Implant was developed to avoid these complications. This study was conducted to compare the result of conventional DCR with Pawar’s silicone implant technique.
Methodology: Sixty patients having chronic Dacryocystitis were randomly equally divided in to two group. One group under gone Pawar’s Implant (Group A) and other group received conventional DCR surgery (Group B).
Results: Time duration required for classical DCR surgery was 60 min to 2 hours, where as in Pawar implant it is 30-45 minute. Size of incision was smaller in Pawar implant compared to conventional DCR surgery. Nasal packing is not required in any case of pawar implant while in conventional DCR surgery pack required for all patients. Bleeding was minimal with Pawar implant while in conventional DCR surgery moderate to severe bleeding observed. Post operative complication rate was lower in Pawar implant (6 patients, 20%) compared to conventional DCR surgery (15 patients, 50%) Nasal bleeding, lid edema was found more in conventional DCR surgery. Out of 60 patient 6 patients had failed in Pawar surgery group while four patients had failed conventional DCR surgery
Conclusion: Pawar implant surgery is very safe, less pain full, less time consuming surgical option for DCR surgery. There were less hospital stay and comparatively equal success rate between conventional DCR and pawar implant surgery. So we recommend pawar implant surgery as a better alternative for dacryocystitis patient’s treatment.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Author/s retain the copyright of their article, with first publication rights granted to Medsci Publications.